What is it about?

There is good evidence from clinical trials for two psychological treatments for schizophrenia: Cognitive Behavioural Therapy for psychosis (CBTp) and Cognitive Remediation (CR). CR aims to improve neurocognitive problems, like poor concentration, memory and planning skills that are common schizophrenia symptoms. CBTp aims to treat delusions, hallucinations and other symptoms that those with schizophrenia can talk over with a therapist to find better ways of dealing with them. There is evidence that problems like poor memory interfere with CBTp. We hypothesised that giving CR to those on waiting lists for CBTp would improve people's neurocognition and help them take part in the CBTp better. We predicted greater improvement in symptoms, or perhaps shorter therapy. We focused on people who had just had their first episode of illness, because those who had been unwell for longer might have worse neurocognitive problems, and symptoms that responded more poorly to CBTp; so getting treatment started early on could avoid some of this deterioration. We divided 61 people randomly into two groups. One had CR before CBTp, lasting three months and delivered using a computer programme that set people tasks in a virtual world that gradually required more and more concentration, memory planning and so on to complete. Thye were helped by support workers to complete the weekly sessions of CR. The other group saw support workers for the same amount of time but had no CR. Both groups then had CBTp from therapists who did not know which group they were in, like the researchers who assessed their symptoms. We found that there was no difference between the two groups in the effect of CBTp on symptoms. However, the group who had CR improved on complicated tasks requiring flexible thinking. They also had more insight into their problems by the end of CBTp than the other group. Finally, as we thought might happen, the CR group had much shorter courses of CBTp - most needed 7 sessions or less, while in the other group most needed 13 sessions or less.

Featured Image

Why is it important?

Most treatments are, like CR and CBTp, usually studied in isolation. Yet clinicians often combine treatments and some combinations might work better than others. NHS services are currently responding to recommendations that everybody receives psychological treatments early in the course of their illness, but this study suggests that CR first might enhance CBTp. It is always difficult to find well trained therapists and something that allows them to see more people (in a shorter time) with the same benefit for each person has to be an advantage for real-world clinical services. The same might be true for people who have been ill longer; we just don't know yet. Also, in our study CR was delivered relatively cheaply, though the support workers we recruited were better qualified than support workers often are. It is important to study how far this makes a difference to CR, which some studies (mostly in well organised rehabilitation in the US) show to be of substantial benefit. There are now studies examining how well different forms of CR work in the NHS, which might reveal novel ways to improve outcomes of an illness that the NHS often struggles to treat with the resources available.

Perspectives

Well conducted meta-analyses (studies that combine the results of numerous trials to produce overall measures of a treatment's value) in recent years found the CBTp (cognitive behavioural therapy for psychosis) and CR (cognitive remediation) were both beneficial. NICE found the same when it reviewed the role of CBTp, but its 2009 meta-analysis was unable to reach a firm conclusion about CR because of concerns about whether some trials should be included. Nonetheless, trials in the US found that CR combined with social skills groups boosted their effect, so we hoped for the same by combining CBTp and CR. We found that although CR did not improve outcomes of CBTp, it seemed to make it more efficient, meaning that therapists could see people more quickly. It was possible to deliver the CR relatively cheaply with less skilled staff, though there is a concern that this can sometimes detract from CR's benefits. I hope our study, combined with ongoing trials looking at how best to deliver CR in the NHS (and the weight of evidence available in the last few years) enable this potentially valuable treatment to find a role.

Professor Richard James Drake
University of Manchester

Read the Original

This page is a summary of: A naturalistic, randomized, controlled trial combining cognitive remediation with cognitive–behavioural therapy after first-episode non-affective psychosis, Psychological Medicine, October 2013, Cambridge University Press,
DOI: 10.1017/s0033291713002559.
You can read the full text:

Read

Contributors

The following have contributed to this page